We evaluate the impact of SARS-CoV-1 infection rates on inbound cross-border mergers & acquisitions (M&As) in China. Using transaction level data on cross-border M&As from 2002 to 2005, we show that Chinese provinces that experienced high level of SARS-CoV-1 infection rates, also suffered a...

We evaluate the impact of the 2003 SARS-CoV-1 epidemic on inbound cross-border M&As in China. Provinces that experienced high level of SARS infection rates, also suffered a significant decline in cross-border M&A activity, both in terms of the number of transactions and the overall dollar...